Myelin endocytosis by brain endothelial cells causes endothelial iron overload and oligodendroglial iron hunger in hypoperfusion‐induced white matter injury

Yuxin Liu, Xinmei Kang, Jiahao Lin, Yixin Liu, Sanxin Liu, Chunyi Li, Xiaohui Deng, Huipeng Huang, Tiemei Li, Shisi Wang, Danli Lu, Yuxuan Jiang, Zhengqi Lu, Wei Cai, Tingting LüCNS 2024 · DOI

TL;DR

This study reveals a novel mechanism in hypoperfusion-induced white matter injury: brain endothelial cells (BVECs) engulf myelin debris, leading to iron overload within the BVECs. This iron trapping impairs iron transport to oligodendrocytes, causing their iron deficiency and hindering myelin repair, suggesting a new therapeutic target for this condition.

What Problem Does This Paper Address?

White matter injury, particularly in conditions like arteriosclerotic cerebral small vessel disease (aCSVD), is a significant cause of neurological dysfunction, especially in the elderly. While hypoperfusion is known to damage white matter and lead to demyelination, the precise mechanisms governing iron homeostasis and its role in myelin repair remain unclear. Specifically, there's a paradox: the injured brain needs iron for remyelination, yet studies have observed iron surplus in the periphery of patients with white matter damage. This paper aims to bridge this gap by investigating the intricate interplay between iron metabolism, brain endothelial cells, and oligodendrocytes in the context of hypoperfusion-induced white matter injury.

Methods

The researchers employed a multi-pronged approach combining in vivo and in vitro techniques:

  • In vivo Model: A unilateral common carotid artery occlusion (UCCAO) model in C57BL/6 mice was used to simulate hypoperfusion-induced white matter injury.
  • In vitro Models:
    • Brain vascular endothelial cells (BVECs) were co-cultured with myelin.
  • BVECs were co-cultured with oligodendrocyte progenitor cells (OPCs) or organotypic cerebellar slices subjected to oxygen and glucose deprivation (OGD).
  • Iron Metabolism Assessment:
    • Serum Analysis: Assessed serum ferritin (SF), total iron binding capacity (TIBC), unsaturated iron binding capacity (UIBC), and serum iron (SI) in both human patients and mice.
  • Tissue Analysis: Used inductively coupled plasma mass spectrometry (ICP-MS) to measure iron concentration in brain tissue.
  • Cellular Iron Assays: Employed flow cytometry with Calcein-AM to assess the labile iron pool (LIP) and BODIPY 581/591 C11 to detect lipid peroxidation, a marker of ferroptosis.
  • Cellular and Molecular Techniques:
    • Western Blot: Analyzed the expression of iron metabolism-related proteins (ferritin, transferrin, ferroportin-1, transferrin receptor) and ferroptosis markers (SLC7A11, GPX-4, FSP-1, ACSL-4).
  • Immunofluorescence Staining: Visualized myelin basic protein (MBP), CD31 (endothelial marker), ZO-1 (tight junction protein), and other cellular markers in brain tissue and cultured cells.
  • Flow Cytometry: Quantified cell populations, protein expression, and cellular iron status.
  • Transmission Electron Microscopy (TEM): Examined ultrastructural changes in BVECs, particularly mitochondria, to identify signs of ferroptosis.
  • Therapeutic Intervention: Intranasal administration of apo-transferrin (aTF) and holo-transferrin (hTF) was used to assess the impact of iron supplementation bypassing the blood-brain barrier (BBB).
  • Barrier Function Assays: Measured sodium fluorescein (NaF) penetration and transendothelial electrical resistance (TEER) to assess BBB integrity.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • BVECs as Iron Trappers: The most striking finding is that BVECs, upon engulfing myelin debris, become iron-loaded. This isn't just passive storage; it actively impedes iron transport from the blood into the brain parenchyma.
  • Oligodendroglial Iron Hunger: This BVEC-mediated iron trapping creates an iron-deficient environment for oligodendrocytes, which are crucial for myelin repair. This directly links myelin debris clearance to impaired remyelination.
  • BVEC Ferroptosis: The iron overload within BVECs triggers ferroptosis, a form of programmed cell death. This not only damages the BVECs themselves but also contributes to BBB disruption.
  • BBB Disruption: Myelin engulfment by BVECs leads to ferroptosis and a breakdown in the tight junctions (like ZO-1) of the BBB, further compromising brain integrity.
  • Therapeutic Potential of BBB-Bypassing Iron: Intranasal administration of holo-transferrin (hTF), which bypasses the BBB, effectively delivers iron to oligodendrocytes, promoting myelin regeneration and improving white matter integrity. This highlights a novel therapeutic strategy.
  • Iron Imbalance as a Core Problem: The study strongly suggests that the dysregulation of iron homeostasis between BVECs and oligodendrocytes is a central issue in hypoperfusion-induced white matter injury.

Key Results

  • Human Patients & Mouse Models: Both aCSVD patients and UCCAO mice showed increased serum ferritin (iron storage) and TIBC/UIBC (iron transport capacity) but decreased serum iron, indicating peripheral iron retention.
  • Brain Iron Reduction: Ipsilateral brain tissue in UCCAO mice showed decreased iron concentration, despite increased demand.
  • BVEC Myelin Engulfment: BVECs were shown to engulf myelin debris both in vivo and in vitro.
  • BVEC Iron Overload & Ferroptosis: Myelin-treated BVECs exhibited increased labile iron pool (LIP) and ferritin, and in vivo BVECs in injured brains showed elevated lipid ROS, a marker of ferroptosis.
  • BBB Impairment: Myelin-engulfed BVECs showed reduced ZO-1 expression and increased permeability (NaF penetration, decreased TEER).
  • hTF Treatment Efficacy: Intranasal hTF administration in UCCAO mice significantly improved oligodendrocyte proliferation and differentiation, increased MBP expression (a marker of myelin), and ameliorated white matter injury. Cognitive function (novel object recognition test) also improved.

Limitations and Future Work

  • Myelin Clearance Complexity: While the study highlights BVEC myelin engulfment, it acknowledges that microglia and astrocytes are the primary myelin clearance cells. The relative contribution of BVECs versus these other cells in different injury contexts warrants further investigation.
  • Iron Transport Pathways: The study focuses on BVEC-mediated iron transport. Further research could explore the specific iron transporters and mechanisms involved in BVEC-oligodendrocyte iron transfer.
  • Therapeutic Optimization: While hTF showed promise, further studies are needed to optimize dosage, delivery methods, and long-term efficacy of BBB-bypassing iron supplementation.
  • Broader Applicability: The findings are primarily from a hypoperfusion model. Investigating the role of BVEC myelin endocytosis and iron dysregulation in other white matter injury etiologies (e.g., inflammatory, traumatic) would be valuable.
  • Apo-transferrin's Role: The study noted some therapeutic effect of apo-transferrin (aTF) despite its lack of iron. Understanding the mechanism behind this effect, beyond iron delivery, could offer additional therapeutic avenues.

Summary updated

Abstract

The iron imbalance between BVECs and oligodendroglial lineage cells is a potential therapeutic target in hypoperfusion-induced white matter injury.
BibTeX
@inproceedings{liu2024myelin,
  author = {Yuxin Liu and Xinmei Kang and Jiahao Lin and Yixin Liu and Sanxin Liu and Chunyi Li and Xiaohui Deng and Huipeng Huang and Tiemei Li and Shisi Wang and Danli Lu and Yuxuan Jiang and Zhengqi Lu and Wei Cai and Tingting Lü},
  title = {{Myelin endocytosis by brain endothelial cells causes endothelial iron overload and oligodendroglial iron hunger in hypoperfusion‐induced white matter injury}},
  booktitle = {CNS},
  year = {2024},
  doi = {10.1111/cns.14925},
}
Figure